Literature DB >> 6094011

Cell surface expression of the McDonough strain of feline sarcoma virus fms gene product (gp 140fms).

R Manger, L Najita, E J Nichols, S Hakomori, L Rohrschneider.   

Abstract

The unique oncogene carried by the McDonough strain of feline sarcoma virus (SM-FeSV), called v-fms, directs the synthesis of a set of related glycoproteins, called gP 180gag-fms, gp 140fms, and gp 120fms. We have prepared antibodies to these proteins and used indirect immunofluorescence techniques on viable SM-FeSV transformed cells to demonstrate that fms-specific determinants are expressed on the external surface. The fms-specific fluorescence co-localized with clathrin and was detectable in clathrin-coated pits and endocytotic vesicles. Two cell surface labeling methods indicated that gp140fms was the only fms-related protein on the cell surface. In view of the relationship between the erbB oncogene product and the epidermal growth factor receptor, and the fact that growth factor receptors utilize clathrin-coated pits in endocytosis, we believe the gp140fms transforming protein of SM-FeSV also could function as an analog of a growth factor receptor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6094011     DOI: 10.1016/0092-8674(84)90011-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  24 in total

1.  Analysis of functional domains of the v-fms-encoded protein of Susan McDonough strain feline sarcoma virus by linker insertion mutagenesis.

Authors:  S D Lyman; L R Rohrschneider
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

2.  Phosphorylation of the fibronectin receptor complex in cells transformed by oncogenes that encode tyrosine kinases.

Authors:  R Hirst; A Horwitz; C Buck; L Rohrschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  Localization of the feline sarcoma virus fgr gene product (P70gag-actin-fgr): association with the plasma membrane and detergent-insoluble matrix.

Authors:  R Manger; S Rasheed; L Rohrschneider
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

4.  Different pathways of colony-stimulating factor 1 degradation in macrophage populations revealed by wortmannin sensitivity.

Authors:  V Kanagasundaram; E Christy; J A Hamilton; A Jaworowski
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

5.  Identification and biochemical characterization of p70TRK, product of the human TRK oncogene.

Authors:  G Mitra; D Martin-Zanca; M Barbacid
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

6.  "Replacement" of COOH-terminal truncation of v-fms with c-fms sequences markedly reduces transformation potential.

Authors:  P J Browning; H F Bunn; A Cline; M Shuman; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

7.  Transforming activity of retroviral genomes encoding Gag-Axl fusion proteins.

Authors:  Q K Zhang; S Boast; K de los Santos; M Begemann; S P Goff
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

8.  The v-fms oncogene induces factor-independent growth and transformation of the interleukin-3-dependent myeloid cell line FDC-P1.

Authors:  E F Wheeler; D Askew; S May; J N Ihle; C J Sherr
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

9.  Separation and characterization of the activated pool of colony-stimulating factor 1 receptor forming distinct multimeric complexes with signalling molecules in macrophages.

Authors:  V Kanagasundaram; A Jaworowski; R Byrne; J A Hamilton
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

10.  A new acute transforming feline retrovirus with fms homology specifies a C-terminally truncated version of the c-fms protein that is different from SM-feline sarcoma virus v-fms protein.

Authors:  P Besmer; E Lader; P C George; P J Bergold; F H Qiu; E E Zuckerman; W D Hardy
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.